Protara Therapeutics, Inc. - TARA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 13, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP Ltd. | 8.4% | 4,696,709 | View |
| Jul 07, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 5.1% | 2,879,674 | View |
| Jul 07, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 5.7% | 3,201,936 | View |
| Jul 07, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 5.7% | 3,201,936 | View |
| Jul 07, 2026 | SCHEDULE 13G/A | Israel A. Englander | 5.7% | 3,201,936 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 9.6% | 5,207,011 | View |
| Apr 27, 2026 | SCHEDULE 13G | BlackRock, Inc. | 6.3% | 3,387,459 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.